These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 17827369)
1. Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial. Nielsen NO; Simonsen PE; Dalgaard P; Krarup H; Magnussen P; Magesa S; Friis H Am J Trop Med Hyg; 2007 Sep; 77(3):507-13. PubMed ID: 17827369 [TBL] [Abstract][Full Text] [Related]
2. The effect of HIV on filarial-specific antibody response before and after treatment with diethylcarbamazine in Wuchereria bancrofti infected individuals. Petersen HH; Nielsen NO; Monrad J; Magesa SM; Simonsen PE Parasitol Int; 2009 Jun; 58(2):141-4. PubMed ID: 19567236 [TBL] [Abstract][Full Text] [Related]
3. Micronutrient status indicators in individuals single- or double-infected with HIV and Wuchereria bancrofti before and after DEC treatment. Nielsen NO; Simonsen PE; Kaestel P; Krarup H; Magnussen P; Magesa S; Friis H Trop Med Int Health; 2009 Jan; 14(1):44-53. PubMed ID: 19017312 [TBL] [Abstract][Full Text] [Related]
4. Co-infection with subclinical HIV and Wuchereria bancrofti, and the role of malaria and hookworms, in adult Tanzanians: infection intensities, CD4/CD8 counts and cytokine responses. Nielsen NO; Friis H; Magnussen P; Krarup H; Magesa S; Simonsen PE Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):602-12. PubMed ID: 17395223 [TBL] [Abstract][Full Text] [Related]
5. Border and imported bancroftian filariases: baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand. Bhumiratana A; Koyadun S; Srisuphanunt M; Satitvipawee P; Limpairojn N; Gaewchaiyo G Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):390-407. PubMed ID: 15916046 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients]. Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327 [TBL] [Abstract][Full Text] [Related]
7. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial. Hurwitz BE; Klaus JR; Llabre MM; Gonzalez A; Lawrence PJ; Maher KJ; Greeson JM; Baum MK; Shor-Posner G; Skyler JS; Schneiderman N Arch Intern Med; 2007 Jan; 167(2):148-54. PubMed ID: 17242315 [TBL] [Abstract][Full Text] [Related]
8. Cross-sectional relationship between HIV, lymphatic filariasis and other parasitic infections in adults in coastal northeastern Tanzania. Nielsen NO; Simonsen PE; Magnussen P; Magesa S; Friis H Trans R Soc Trop Med Hyg; 2006 Jun; 100(6):543-50. PubMed ID: 16324731 [TBL] [Abstract][Full Text] [Related]
9. Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine. Mand S; Pfarr K; Sahoo PK; Satapathy AK; Specht S; Klarmann U; Debrah AY; Ravindran B; Hoerauf A Am J Trop Med Hyg; 2009 Oct; 81(4):702-11. PubMed ID: 19815891 [TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled study with diethylcarbamazine for the treatment of hydrocoele in an area of Tanzania endemic for lymphatic filariasis. Bernhard P; Magnussen P; Lemnge MM Trans R Soc Trop Med Hyg; 2001; 95(5):534-6. PubMed ID: 11706668 [TBL] [Abstract][Full Text] [Related]
11. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy. Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E; Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946 [TBL] [Abstract][Full Text] [Related]
12. CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy. Steel A; John L; Shamji MH; Henderson DC; Gotch FM; Gazzard BG; Kelleher P HIV Med; 2008 Feb; 9(2):118-25. PubMed ID: 18257774 [TBL] [Abstract][Full Text] [Related]
13. Tolerance and efficacy of combined diethylcarbamazine and albendazole for treatment of Wuchereria bancrofti and intestinal helminth infections in Haitian children. Fox LM; Furness BW; Haser JK; Desire D; Brissau JM; Milord MD; Lafontant J; Lammie PJ; Beach MJ Am J Trop Med Hyg; 2005 Jul; 73(1):115-21. PubMed ID: 16014845 [TBL] [Abstract][Full Text] [Related]
14. Effect of oral immunomodulator Dzherelo in TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOTS. Nikolaeva LG; Maystat TV; Pylypchuk VS; Volyanskii YL; Masyuk LA; Kutsyna GA Int Immunopharmacol; 2008 Jun; 8(6):845-51. PubMed ID: 18442788 [TBL] [Abstract][Full Text] [Related]
15. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India. Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007 [TBL] [Abstract][Full Text] [Related]
16. A study of the CD4: CD8 ratio in peripheral T lymphocytes of rural Papua New Guineans: a reduced ratio assessed with regard to infectious agents. Turner PF P N G Med J; 1993 Sep; 36(3):210-4. PubMed ID: 8059546 [TBL] [Abstract][Full Text] [Related]
17. [CD8+ cell noncytotoxic antiviral response (CNAR) to HIV in nosocomial HIV-infected individuals]. Yuan L; Ma LY; Zang XH; Meng XD; Peng H; Zhao QB; Xing H; Shao YM Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):195-7. PubMed ID: 19031701 [TBL] [Abstract][Full Text] [Related]
18. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Ciuffreda D; Comte D; Cavassini M; Giostra E; Bühler L; Perruchoud M; Heim MH; Battegay M; Genné D; Mulhaupt B; Malinverni R; Oneta C; Bernasconi E; Monnat M; Cerny A; Chuard C; Borovicka J; Mentha G; Pascual M; Gonvers JJ; Pantaleo G; Dutoit V Eur J Immunol; 2008 Oct; 38(10):2665-77. PubMed ID: 18958874 [TBL] [Abstract][Full Text] [Related]
19. Phase II placebo-controlled study of V-1 Immunitor as a therapeutic modality for treatment of HIV. Bourinbaiar AS; Jirathitikal V; Metadilogkul O; Sooksathan P; Paiboon P; Aemsri S; Prapai P; Chaodon K J Clin Virol; 2004 Dec; 31 Suppl 1():S55-62. PubMed ID: 15567095 [TBL] [Abstract][Full Text] [Related]
20. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals. Kolber MA AIDS; 2008 Oct; 22(15):1937-41. PubMed ID: 18784457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]